Key result
Essential thrombocythemia can present as STEMI complicated by acute stent thrombosis.
Why the study?
Patients with essential thrombocythemia have an increased risk of acute coronary syndrome and stent thrombosis, but the optimal management and antiplatelet therapy remain uncertain.
Case Report (n=1)
This case illustrates that underlying essential thrombocythemia can present as STEMI and severely heightens the risk of acute stent thrombosis during primary percutaneous coronary intervention.
May prompt hematologic evaluation in STEMI with hyperacute stent thrombosis; single case leaves open screening utility and generalizability.
This paper presents a patient with acute coronary syndrome and 100% mid-left anterior descending artery occlusion, complicated by acute stent thrombosis. Subsequent work-up revealed essential thrombocythemia. This case highlights the increased risk of acute coronary syndrome and stent thrombosis in essential thrombocythemia, emphasizing the need for multidisciplinary management.
No takes yet. Share an insight, caveat, or question.
Teeri et al. (2025) conducted a case report in Essential Thrombocythemia and ST-Segment Elevation Myocardial Infarction (n=1). Essential thrombocythemia was evaluated. Essential thrombocythemia can initially present as ST-segment elevation myocardial infarction complicated by acute stent thrombosis, highlighting the extreme thrombotic risk in these patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: